Kanaly Trust’s NuVasive, Inc. NUVA Stock Holding History

Kanaly Trust’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-82	Closed	-$4K	–	938
2015 Q4	$4K	Hold	82	–	–	﹤0.01%	708
2015 Q3	$4K	Buy	+82	New	+$4.24K	﹤0.01%	691

Other funds holding NUVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kanaly Trust's NUVA Position: Q1 2016 in Review

Kanaly Trust sold out of NuVasive, Inc. (NUVA) in Q1 2016, closing a stake of 82 shares — an estimated $4K sold.

Kanaly Trust first reported a position in NUVA in Q3 2015 and held it in 2 quarters. The position peaked at $4K in Q4 2015. 249 funds tracked by Wall St. Rank hold NUVA as of Q1 2016.

Kanaly Trust reported no remaining NuVasive, Inc. position as of Q1 2016 after selling out during the quarter.
Kanaly Trust sold 82 NuVasive, Inc. shares in Q1 2016, an estimated $4K.
Kanaly Trust first reported a position in NuVasive, Inc. in Q3 2015 and held it in 2 quarters.
Kanaly Trust's NuVasive, Inc. position peaked at $4K in Q4 2015.
249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2016.

Based on Kanaly Trust's 13F filing for Q1 2016, filed 13 Apr 2016.